期刊文献+

氨基末端B型利钠肽与超声心动图在心力衰竭病因中的价值 被引量:1

Investigation of the value of amino terminal B type natriuretic peptide and ultrasonic heartbeat diagram in the pathogeny of heart failure
下载PDF
导出
摘要 目的:探讨超声心动图心脏结构异常的心脏病心力衰竭患者与氨基末端B型利钠肽(NT-proBNP)的相关性及临床价值,对病情预后进行评估。方法:2012年1月-2014年5月收治心力衰竭(HF)患者800例,比较分析不同患者的氨基末端B型利钠肽(NT-proBNP)水平与超声心动图显示心脏结构异常之间的相关性,并且评估患者的预后情况。结果:血浆NT-proBNP的水平与患者的心功能不全呈正相关关系,心衰的程度越严重,NT-proBNP的水平越高(P<0.05),并且血浆NT-proBNP值与LVEF呈显著负相关(P<0.05)。结论:血浆NT-proBNP的水平与患者心力衰竭程度有相关性,可以作为心衰的诊断标准。 Objective:To explore the relationship of heart failure patients with abnormal cardiac structure in ultrasonic heartbeat diagram and NT-proBNP and clinical significance,to evaluate the prognosis of the disease.Methods:800 cases with heart failure were selected from January 2012 to May 2014.We compared and analyzed the relationship of heart failure patients with abnormal cardiac structure in ultrasonic heartbeat diagram and NT-proBNP in different patients and evaluated the prognosis of the disease.Results:Through the experiment,the levels of plasma NT-proBNP had positive correlation with the heart function in patients with heart failure.The more serious of the degree of heart failure,the higher of the level of NT-proBNP(P<0.05).Moreover,the plasma NT-proBNP level was negatively correlated with LVEF(P<0.05).Conclusion:There is a correlation between the level of plasma NT-proBNP and degree of heart failure,and it can be used as diagnostic standard of heart failure.
出处 《中国社区医师(医学专业)》 2014年第19期113-114,共2页
关键词 氨基末端B型利钠肽 超声心动图 心力衰竭 The amino terminal B type natriuretic peptide Ultrasonic heartbeat diagram Heart failure
  • 相关文献

参考文献6

二级参考文献56

  • 1贺正一.急诊症状处理——急性发作性呼吸困难[J].中国临床医生杂志,2005,33(3):50-52. 被引量:4
  • 2汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 3赵昕,王萌.N端脑钠肽前体对心力衰竭诊断价值的研究[J].中国老年学杂志,2007,27(13):1287-1289. 被引量:51
  • 4Wiese CH, Barrels UE, Graf BM, et al. Out-of-hospital opioid therapy of palliative care patients with "acute dyspnoea": a retrospective multicenter investigation. J Opioid Manag,2000,5: 115-122.
  • 5Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol,2005,95:948-954.
  • 6Baggish AL, Siebert U, Lainchbury JG, et al. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. Am Heart J,2006,151:48-54.
  • 7Januzzi JL, Van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure :an international pooled analysis of 1 256 patients :the International Collaborative of NT-proBNP Study. Eur Heart J,2006,27:330-337.
  • 8Berdague P, Caffin PY, Barazer I, et al. Use N-terminal prohormone brain natrluretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Am Heart J,2006,151:690-698.
  • 9Hildebrandt P, Collinson PO. Aminoterminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of'heart failure in symptomatic primary care patient. Am J Cardiol,2008, 101:25-28.
  • 10Reny JL, Millot O, Vanderecamer T, et al. Admission NT-proB- NP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea. Eur J Intern Med,2009,20:14-19.

共引文献27

同被引文献10

引证文献1

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部